Kidney trace metal response to combined cisplatin (CDDP) and hyperthermia

References

• Alberts D. S., Peng Y-M, Chen H. 4. G., Moon T. E., Cetas T. C., Hoeschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. Journal of the National Cancer Institute 1980; 65(2)455–460
   PubMedGoogle Scholar
• Baba H., Siddik Z. H., Strebel F. R., Kenkins G. N., Bull J. C. Increased therapeutic gain of combined cis-diamminedichloroplatinum(II) and whole body hyperthermia therapy by optimal heat/drug scheduling. Cancer Research 1989; 49: 7041–7044
   PubMed Web of Science ®Google Scholar
• Banerjee D., Onosaka S., Cherian M. G. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology 1982; 24: 95–105
   PubMed Web of Science ®Google Scholar
• Buchman T. G., Cabin D. E., Porter J. M., Bulkley G. B. change in hepatic gene expression after shock/resuscitation. Surgery 1989; 106(2)283–290
   PubMed Web of Science ®Google Scholar
• Currie R. W., White F. P. Characterization of the synthesis and accumulation of a 71 -kilodalton protein induced in rat tissues after hyperthennia. Canadian Journal Biochemistry and Cell Biology 1983; 61: 438–446
   PubMedGoogle Scholar
• DeWoskin R. S., Riviere J. E. Effects of copper or bismuth preloading or DDTC rescue on cisplatin nephrotoxicity and kidney metal concentrations. rite Toxicologist 1989; 9(1)175
   Google Scholar
• DeWoskin R. S., Riviere J. E. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna. Toxicology and Applied Pharmacology 1992; 112: 182–189
   PubMed Web of Science ®Google Scholar
• Gerad H., Egorin M. J., Whitacre M., Van Echo D. A., Aisner J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia. Cancer Chemotherapy and Pharmacology 1983; 11: 162–166
   PubMed Web of Science ®Google Scholar
• Hahn G. M. Potential for therapy of drugs and hyperthermia. Cancer Research 1979; 39: 2264–2268
   PubMed Web of Science ®Google Scholar
• Hart B. A., Voss G. W., Garvey J. S. Induction of pulmonary metallothionein following oxygen exposure. Environmental Research 1989; 50(2)268–278
   Web of Science ®Google Scholar
• Haywood S., Loughran M., Batt R. M. Copper toxicosis and tolerance in the rat. III. Intracellular localization of copper in the liver and kidney. Experimental and Molecular Pathology 1985; 43: 209–219
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Chan V., Collins L. S., Kaufmann M. E., Loh C. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 1232 [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachlorinate in vitro and in vivo. Cancer Research 1988; 48: 2335–2341
   PubMed Web of Science ®Google Scholar
• Lewis C. D., Laemmli U. K. Higher order metaphase chromosome structure, evidence for metalloprotein interactions. Cell 1982; 29(1)171–181
   PubMed Web of Science ®Google Scholar
• Mella O. Combined hyperthermia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4A tumors. International Journal of Hyperthermia 1985; 1(2)171–183
   PubMedGoogle Scholar
• Mella O., Eriksen R., Dahl O., Laerum O. D. Acute systemic toxicity of combined, cis-diamminedichloroplatinum and hyperthermia in the rat. European Journal of Cancer and Clinical Oncology 1987; 23(4)365–373
   PubMedGoogle Scholar
• Meyn R. E., Corry P. M., Fletcher S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Research 1980; 40: 1136–1139
   PubMed Web of Science ®Google Scholar
• Nordberg G. F., Andersen O. Metal interactions in carcinogenesis, enhancement, inhibition. Environmental Health Perspectives 1981; 40: 65–81
   PubMed Web of Science ®Google Scholar
• Nordberg G. F., Vouk V. B. Factors influencing metabolism and toxicity of metals, a consensus report by the Task Group on Metal Interactions. Environmental Health Perspectives 1978; 25: 3–41
   PubMed Web of Science ®Google Scholar
• Riviere J. E., Page R. L., Rogers R. A., Chang S. K., Dewhirst M. W., Thrall D. E. Non-uniform alteration of cis-diamminedichloroplatinum(II) tissue distribution in dogs with whole body hyperthermia. Cancer Research 1990; 50: 2075–2080
   PubMed Web of Science ®Google Scholar
• Silar P., Butler G., Thiele D. J. Heat shock transcription factor activates transcription of the yeast, metallothionein gene. Molecular and Cellular Biology 1991; 11(3)1232–1238
   PubMed Web of Science ®Google Scholar
• Wallner K. E., DeGregorio M. W., LI G. C. Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese Hamster Ovary cells resistant to the drug. Cancer Research 1986; 46: 6242–6245
   PubMed Web of Science ®Google Scholar
• Wondergem J., Bulger R. E., Strebel F. R., Newman R. A., Travis E. L., Stephens L. C., Bull J. C. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Research 1988a; 48: 440–446
   PubMed Web of Science ®Google Scholar
• Wondergem J., Strebel F. R., Siddik Z. H., Newman R. A., Bull J. C. The effects of anesthetic on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia, the influence of NaCl concentration of the vehicle. International Journal of Hyperthermia 1988b; 4(6)643–654
   PubMed Web of Science ®Google Scholar
• Yang W. M., Gahl W., Hamer D. Role of heat shock transcription factor in yeast metallothionein gene expression. Molecular and Cellular biology 1991; 11(7)3676–3681
   PubMed Web of Science ®Google Scholar